Response to comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?
Corresponding author: Ralph A. DeFronzo, albarado@uthscsa.edu.
Stanley
S
Schwartz
Ralph A
RA
Defronzo
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists*
D054795:Incretins; D018027:Receptors, Glucagon